Income Tax Disclosure [Abstract] Provision (benefit) for income taxes Income Tax Expense (Benefit) Reported tax rate Effective Income Tax Rate Reconciliation, Percent Discrete tax provision Tax Adjustments, Settlements, and Unusual Provisions Income Statement [Abstract] Net revenues Sales Revenue, Goods, Net Cost of goods sold Cost of Goods Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Total operating expenses Operating Expenses Operating income Operating Income (Loss) Gain on divestiture Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal Interest and other expense, net Other Nonoperating Income (Expense) Income before provision for income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Provision for income taxes Net income Net Income (Loss) Attributable to Parent Net earnings per share - basic (in dollars per share) Earnings Per Share, Basic Net earnings per share - diluted (in dollars per share) Earnings Per Share, Diluted Weighted average shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Stockholders' Equity Note [Abstract] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments Derivative Instruments, Gain (Loss) [Table Text Block] Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Foreign Currency Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Defined Benefit Plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Net Unrealized Gain/Loss on Derivatives Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Balance as of April 1, 2017 Accumulated Other Comprehensive Income (Loss), Net of Tax Other comprehensive income (loss) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Amounts reclassified from Accumulated Other Comprehensive Income (Loss) Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Balance as of September 30, 2017 Inventory Disclosure [Abstract] Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Discontinued Operations and Disposal Groups [Abstract] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Group Name [Domain] Disposal Group Name [Domain] SEBRA Sealers Product Line [Member] SEBRA Sealers Product Line [Member] SEBRA Sealers Product Line [Member] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Proceeds from divestiture Proceeds from Divestiture of Businesses Restructuring and Related Activities [Abstract] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Japan JAPAN EMEA EMEA [Member] North America Plasma North America Plasma [Member] North America Plasma [Member] All Other Other Segments [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Severance and Other Employee Costs Employee Severance [Member] Other Costs Other Restructuring [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring costs Restructuring Charges Turnaround costs Restructuring Related Costs Restructuring Related Costs Total restructuring and turnaround costs Restructuring and Restructuring Related Costs Restructuring and Restructuring Related Costs Segment Reporting [Abstract] SEGMENT AND ENTERPRISE-WIDE INFORMATION Segment Reporting Disclosure [Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Restructuring Plan [Axis] Restructuring Plan [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] 2018 Program [Member] 2018 Program [Member] 2018 Program [Member] 2017 Program [Member] 2017 Program [Member] 2017 Program [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Expected cost Restructuring and Related Cost, Expected Cost Restructuring and turnaround costs Restructuring liability Restructuring Reserve Restructuring liability payable in next twelve months Restructuring Charges Payable In Next Twelve Months Restructuring Charges Payable In Next Twelve Months Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Schedule of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] ACCUMULATED OTHER COMPREHENSIVE LOSS Stockholders' Equity Note Disclosure [Text Block] Derivative [Table] Derivative [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Net revenues, COGS, and SG&A Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense [Member] Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Foreign Exchange Contract Foreign Exchange Contract [Member] Cash Flow Hedging Cash Flow Hedging [Member] Interest Rate Swap [Member] Interest Rate Swap [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Derivative [Line Items] Derivative [Line Items] Percentage of sales generated outside the US Percentage Of Net Sales Generated Outside Of The US Percentage Of Net Sales Generated Outside Of The US Maturity period for foreign currency contracts Average Remaining Maturity of Foreign Currency Derivatives Designated foreign currency hedge contracts outstanding Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion) Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Gain (loss) to be reclassified within the next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Non-designated foreign currency hedge contracts outstanding Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net Number of interest rate derivatives held Number of Interest Rate Derivatives Held Deferred income tax expense (benefit) Deferred Tax Assets, Derivative Instruments Notional amount of derivative Derivative, Notional Amount Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Schedule of Quantifying Prior Year Misstatement Corrected in Current Year Financial Statements [Table] Schedule of Quantifying Prior Year Misstatement Corrected in Current Year Financial Statements [Table] Nature of Error [Axis] Nature of Error [Axis] Nature of Error [Domain] Nature of Error [Domain] Overstatement of Net Income [Member] Overstatement of Net Income [Member] Overstatement of net income [Member] Quantifying Misstatement in Current Year Financial Statements [Line Items] Quantifying Misstatement in Current Year Financial Statements [Line Items] Amount of correction Quantifying Misstatement in Current Year Financial Statements, Amount Earnings Per Share [Abstract] Basic EPS Earnings Per Share, Basic [Abstract] Net income Basic weighted average shares (in shares) Basic income per share (in dollars per share) Diluted EPS Earnings Per Share, Diluted [Abstract] Net effect of common stock equivalents (in shares) Weighted Average Number Diluted Shares Outstanding Adjustment Diluted weighted average shares (in shares) Diluted income per share (in dollars per share) Anti-dilutive shares excluded (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount DIVESTITURE Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Schedule of Earnings Per Share Reconciliation Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other Current Assets Other Current Assets [Member] Other Current Liabilities Other Current Liabilities [Member] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring [Member] Fair Value, Measurements, Recurring [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Quoted Market Prices for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets Assets, Fair Value Disclosure [Abstract] Money market funds Investments, Fair Value Disclosure Designated foreign currency hedge contracts Foreign Currency Contract, Asset, Fair Value Disclosure Derivative Assets Derivative Asset, Fair Value, Gross Asset Designated interest rate swaps Derivative Asset Assets fair value Assets, Fair Value Disclosure Liabilities Liabilities, Fair Value Disclosure [Abstract] Designated foreign currency hedge contracts Foreign Currency Contracts, Liability, Fair Value Disclosure Derivative Liabilities Derivative Liability, Fair Value, Gross Liability Liabilities fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Derivative Assets: Derivative Asset, Fair Value, Amount Not Offset Against Collateral [Abstract] Derivative Liabilities: Derivative Liability, Fair Value, Amount Not Offset Against Collateral [Abstract] DERIVATIVES AND FAIR VALUE MEASUREMENTS Derivatives and Fair Value [Text Block] RESTRUCTURING Restructuring and Related Activities Disclosure [Text Block] Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Non-cash items: Non-Cash Items [Abstract] Non-Cash Items [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Gain on divestiture Stock-based compensation expense Share-based Compensation Provision for losses on accounts receivable and inventory Provision for Loan, Lease, and Other Losses Impairment of assets Other Asset Impairment Charges Other non-cash operating activities Other Operating Activities, Cash Flow Statement Change in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Change in accounts receivable Increase (Decrease) in Accounts Receivable Change in inventories Increase (Decrease) in Inventories Change in prepaid income taxes Increase (Decrease) in Prepaid Taxes Change in other assets and other liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Change in accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash Flows from Investing Activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash Flows from Financing Activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Repayment of term loan borrowings Repayments of Long-term Debt Proceeds from employee stock purchase plan Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP Proceeds from exercise of stock options Proceeds from Stock Options Exercised Net increase (decrease) in short-term loans Proceeds from (Repayments of) Short-term Debt Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rates on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net Change in Cash and Cash Equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents at Beginning of Period Cash and Cash Equivalents, at Carrying Value Cash and Cash Equivalents at End of Period Supplemental Disclosures of Cash Flow Information: Supplemental Cash Flow Information [Abstract] Interest paid Interest Paid, Net Income taxes paid Income Taxes Paid, Net Transfers from inventory to fixed assets for placement of Haemonetics equipment Transfers from Inventory to Fixed Assets Transfers from inventory to fixed assets. Product Warranties Disclosures [Abstract] General Warranty Period on Parts and Labor General Warranty Period on Parts and Labor General Warranty Period on Parts and Labor Product Warranties [Roll Forward] Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Warranty accrual as of the beginning of the period Standard and Extended Product Warranty Accrual Warranty provision Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Warranty spending Standard and Extended Product Warranty Accrual, Decrease for Payments Warranty accrual as of the end of the period Raw materials Inventory, Raw Materials, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventories, net Inventory, Net New Accounting Pronouncements and Changes in Accounting Principles [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2016-09 [Member] Accounting Standards Update 2016-09 [Member] Accounting Standards Update 2016-09 [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Cumulative-effect adjustment to accumulated deficit and deferred tax assets for certain off balance sheet federal and state net operating loss carry-forwards INCOME TAXES Income Tax Disclosure [Text Block] RECENT ACCOUNTING PRONOUNCEMENTS New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Interest and other expense, net Other Income (Expense), Net [Member] Other Income (Expense), Net [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Amount of Gain (Loss) Recognized in AOCI (Effective Portion) Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Amount Excluded from Effectiveness Testing Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net Research and Development [Abstract] CAPITALIZATION OF SOFTWARE DEVELOPMENT COSTS Research, Development, and Computer Software Disclosure [Text Block] Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Accounts receivable, less allowance of $2,224 at September 30, 2017 and $2,184 at April 1, 2017 Accounts Receivable, Net, Current Inventories, net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property, plant and equipment, net Property, Plant and Equipment, Net Intangible assets, less accumulated amortization of $232,714 at September 30, 2017 and $215,772 at April 1, 2017 Finite-Lived Intangible Assets, Net Goodwill Goodwill Deferred tax asset Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Other long-term assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Notes payable and current maturities of long-term debt Long-term Debt, Current Maturities Accounts payable Accounts Payable, Current Accrued payroll and related costs Employee-related Liabilities, Current Other liabilities Other Liabilities, Current Total current liabilities Liabilities, Current Long-term debt, net of current maturities Long-term Debt, Excluding Current Maturities Deferred tax liability Deferred Tax Liabilities, Net, Noncurrent Other long-term liabilities Other Liabilities, Noncurrent Total stockholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Common stock, $0.01 par value; Authorized — 150,000,000 shares; Issued and outstanding — 52,694,556 shares at September 30, 2017 and 52,255,495 shares at April 1, 2017 Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital, Common Stock Retained earnings Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Total stockholders’ equity Stockholders' Equity Attributable to Parent Total liabilities and stockholders’ equity Liabilities and Equity INVENTORIES Inventory Disclosure [Text Block] Document And Entity Information [Abstract] Document and Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Schedule of Product Warranty Liability Schedule of Product Warranty Liability [Table Text Block] Number of business units Number of Operating Segments Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] Corporate operating expenses Corporate, Non-Segment [Member] All Other Americas Blood Center and Hospital and Asia - Pacific [Member] Americas Blood Center and Hospital and Asia - Pacific [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] United States UNITED STATES Japan Europe Europe [Member] Asia Asia [Member] Other Other Country or Region [Member] Other Country or Region [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Plasma [Member] Plasma [Member] Plasma [Member] Blood Center [Member] Blood Center [Member] Blood Center [Member] Cell Processing Management [Member] Cell Processing [Member] Cell Processing [Member] Hemostasis Management [Member] Hemostasis Management [Member] Hemostasis Management [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Net Revenues, Before Foreign Exchange Impact Net Revenues, Before Foreign Exchange Impact Net Revenues, Before Foreign Exchange Impact Effect of exchange rates Effect of Exchange Rate on Revenues Effect of Exchange Rate on Revenues Net revenues (reported) Corporate operating expenses Corporate Operating Expenses Corporate Operating Expenses Effect of exchange rates Effect of Exchange Rates on Operating Income Effect of Exchange Rates on Operating Income Restructuring and turnaround costs Restructuring and Turnaround Costs Restructuring and Turnaround Costs Deal amortization Amortization Impairment of assets Asset Impairment Charges EARNINGS PER SHARE (EPS) Earnings Per Share [Text Block] Capitalized software development costs for ongoing initiatives Research and Development Expense, Software (Excluding Acquired in Process Cost) Software costs capitalized, net Capitalized Computer Software, Net Total costs capitalized related to in process software development initiatives Capitalized Software Development Costs for Software Sold to Customers Capitalized software development costs placed into service Capitalized Software Development Costs Placed into Service Capitalized Software Development Costs Placed into Service PRODUCT WARRANTIES Product Warranty Disclosure [Text Block] Accounts receivable, allowance Allowance for Doubtful Accounts Receivable, Current Intangible assets, amortization Finite-Lived Intangible Assets, Accumulated Amortization Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Restructuring Reserve [Roll Forward] Balance at April 1, 2017 Costs incurred, net of reversals Payments Payments for Restructuring Balance at September 30, 2017 Loss Contingencies [Table] Loss Contingencies [Table] Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] Italian Employment Litigation [Member] Italian Employment Litigation [Member] Italian Employment Litigation [Member] SOLX Arbitration [Member] SOLX Arbitration [Member] SOLX Arbitration [Member] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Product Recall Damages from Product Defects [Member] Contract Termination [Member] Contract Termination [Member] Performance Guarantee [Member] Performance Guarantee [Member] Up-front Payment Arrangement [Member] Up-front Payment Arrangement [Member] Customer Returns and Inventory Reserves [Member] Customer Returns and Inventory Reserves [Member] Customer Returns and Inventory Reserves [Member] Customer Claims [Member] Customer Claims [Member] Customer Claims [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Damages claimed Loss Contingency, Damages Sought, Value Estimate of possible loss Loss Contingency, Estimate of Possible Loss Loss in period Loss Contingency, Loss in Period Amount accrued Loss Contingency Accrual Payments under previous acquisition Business Combination, Consideration Transferred Contingent milestone payment Contingent Milestone Payment Contingent Milestone Payment Maximum future royalty payments Royalty Guarantees, Commitments, Amount Royalty Term Royalty Term Royalty Term Insurance settlements receivable Insurance Settlements Receivable Selected Information by Business Segment Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of Revenues by Product Line and Geographic Regions Reconciliation of Revenue from Segments to Consolidated [Table Text Block]